New York Presbyterian Hospital-Columbia University Med. Ctr. – FDA 483, Nov 28, 2023
An FDA inspection of New York Presbyterian Hospital-Columbia University Med. Ctr.'s Blood Bank revealed significant deficiencies across four observations. The firm failed to maintain adequate quality control and general records, including analyzer validation and reagent documentation. Additionally, standard operating procedures for blood component compatibility testing and distribution were not consistently established or followed, and records were not always maintained concurrently. Equipment calibration was also found to be non-compliant with SOPs.
- Inspection date
- November 28, 2023
- Product type
- biologics
ID · 02ce9a26-28c4-42dd-8303-fcfde6636d0d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.